Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
JACC Cardiovasc Interv. 2017 May 8;10(9):906-914. doi: 10.1016/j.jcin.2017.01.026.
This study sought to compare long-term clinical outcome in ST-segment elevation myocardial infarction (STEMI) patients with a concomitant chronic total occlusion (CTO) with well-developed versus poorly developed collaterals toward the CTO.
In STEMI patients, presence of a CTO is associated with increased morbidity and mortality. CTOs are often (partially) perfused by collateral vessels. Therefore, when the infarct-related artery (IRA) is the main donor vessel for the collateral blood supply of the CTO, infarct size may increase significantly. Well-developed collaterals to the infarct related vessel have been associated with improved clinical outcome after STEMI. However, the impact of well-developed collaterals toward a concomitant CTO in STEMI patients is unknown.
Consecutive STEMI patients with a CTO in a non-IRA presenting for primary percutaneous coronary intervention (PCI) were divided according to the presence of angiographic, well-developed (grade 2 to 3) or poorly developed collaterals (grade 0 to 1).
Between 2000 and 2012 we included 413 STEMI patients with a single concomitant CTO. Well-developed collaterals to the CTO were present in 53%. Associated with poorly developed collaterals to the CTO were cardiogenic shock (hazard ratio [HR]: 1.8; 95% confidence interval [CI]: 1.11 to 3.07; p = 0.02), CTO located in the left circumflex artery (HR: 1.9; 95% CI: 1.00 to 3.43; p = 0.05), CTO diameter ≤2.5 mm (HR: 2.1; 95% CI: 1.07 to 4.12; p = 0.03), and CTO tapering (HR: 1.9; 95% CI: 1.21 to 2.85; p < 0.001). Patients with well-developed collaterals to the CTO had a better 5-year survival compared to those with poorly developed collaterals (74% vs. 63%; p = 0.01). The presence of well-developed collaterals to the CTO was independently associated with improved survival (HR: 1.5; 95% CI: 1.03 to 2.10; p = 0.04).
In STEMI patients with a CTO in a non-IRA, the presence of well-developed collaterals to the CTO is associated with improved survival.
本研究旨在比较伴有慢性完全闭塞(CTO)的 ST 段抬高型心肌梗死(STEMI)患者中,向 CTO 侧侧支循环良好与不良的患者的长期临床预后。
在 STEMI 患者中,CTO 的存在与发病率和死亡率的增加相关。CTO 通常(部分)由侧支血管供血。因此,当梗死相关动脉(IRA)是 CTO 侧支血供的主要供体血管时,梗死面积可能会显著增加。向 IRA 侧支循环良好的侧支循环与 STEMI 后临床预后改善相关。然而,STEMI 患者向伴发 CTO 的侧支循环良好的影响尚不清楚。
连续纳入 2000 年至 2012 年间因首次经皮冠状动脉介入治疗(PCI)就诊的 IRA 非罪犯病变的 CTO 相关 STEMI 患者,根据是否存在血管造影显示的侧支循环良好(分级 2 至 3 级)或不良(分级 0 至 1 级)进行分组。
共纳入 413 例伴有单一 CTO 的 STEMI 患者,其中 53%存在向 CTO 侧支循环良好。与向 CTO 侧支循环不良相关的因素包括心源性休克(危险比[HR]:1.8;95%置信区间[CI]:1.11 至 3.07;p=0.02)、CTO 位于左回旋支(HR:1.9;95%CI:1.00 至 3.43;p=0.05)、CTO 直径≤2.5mm(HR:2.1;95%CI:1.07 至 4.12;p=0.03)和 CTO 逐渐变细(HR:1.9;95%CI:1.21 至 2.85;p<0.001)。与向 CTO 侧支循环不良的患者相比,向 CTO 侧支循环良好的患者 5 年生存率更高(74% vs. 63%;p=0.01)。向 CTO 侧支循环良好与生存率提高独立相关(HR:1.5;95%CI:1.03 至 2.10;p=0.04)。
在 IRA 非罪犯病变的 CTO 相关 STEMI 患者中,向 CTO 侧支循环良好与生存率提高相关。